رفتن به محتوا

تداخل‌های دارویی

Buprenorphine long-acting + Ethosuximide

شدت: شدید

Buprenorphine long-acting and Ethosuximide: major interaction.

آخرین به‌روزرسانی

ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.

محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.

خلاصه

Concurrent use of long-acting injectable buprenorphine with a CNS depressant such as ethosuximide increases the risk of sedation and respiratory depression. The depot effect means the opioid cannot be quickly withdrawn if problems occur.

معنای این تداخل به زبان ساده

Buprenorphine long-acting and Ethosuximide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

سطح شواهد: Moderate

چرا رخ می‌دهد

Additive CNS and respiratory depression.

اقدام لازم

Monitor for oversedation and respiratory depression, particularly after injection and with ethosuximide dose changes. Avoid additional sedatives and alcohol.

از داروساز چه بپرسید

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

ویژه اعضای Pro+

باز کردن کل صفحه

یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Buprenorphine long-acting و Ethosuximide، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.

پرسش‌های متداول

Can I take Buprenorphine long-acting with Ethosuximide?

MediHelp rates the interaction as major. Buprenorphine long-acting and Ethosuximide can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Concurrent use of long-acting injectable buprenorphine with a CNS depressant such as ethosuximide increases the risk of sedation and respiratory depression. The depot effect means the opioid cannot be quickly withdrawn if problems occur.

How serious is the interaction between Buprenorphine long-acting and Ethosuximide?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for oversedation and respiratory depression, particularly after injection and with ethosuximide dose changes. Avoid additional sedatives and alcohol.

What other medicines interact with Ethosuximide?

MediHelp also lists interactions of Ethosuximide with, for example, Benzhydrocodone / acetaminophen, Buprenorphine subdermal implant, Buprenorphine transdermal. The full list is on the Ethosuximide page.

تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp

مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.

مرور از A تا Z · تداخل‌های دارویی

دریافت برنامه ورود